Novo Nordisk A/s
Clinical trials sponsored by Novo Nordisk A/s, explained in plain language.
-
Obesity drug study ends early, but Real-World data may still help
Disease control TerminatedThis study aimed to see how well semaglutide works for weight loss in everyday medical practice, outside of a strict research setting. It involved 100 adults with obesity who were already planning to take the drug. The study was stopped early, so results are limited, but it may s…
Sponsor: Novo Nordisk A/S • Aim: Disease control
Last updated Jun 22, 2026 12:08 UTC
-
Scientists hunt for genes that predict growth hormone success in short kids
Knowledge-focused TerminatedThis study collected genetic information from 43 children with idiopathic short stature (short stature with no known cause) who had already received growth hormone treatment for at least a year before puberty. The goal was to find genetic differences between those who responded w…
Sponsor: Novo Nordisk A/S • Aim: Knowledge-focused
Last updated Jun 22, 2026 12:07 UTC